Cite
Nootkatone confers antifibrotic effect by regulating the TGF-β/Smad signaling pathway in mouse model of unilateral ureteral obstruction.
MLA
Gairola, Shobhit, et al. “Nootkatone Confers Antifibrotic Effect by Regulating the TGF-β/Smad Signaling Pathway in Mouse Model of Unilateral Ureteral Obstruction.” European Journal of Pharmacology, vol. 910, Nov. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejphar.2021.174479.
APA
Gairola, S., Ram, C., Syed, A. M., Doye, P., Kulhari, U., Mugale, M. N., Murty, U. S., & Sahu, B. D. (2021). Nootkatone confers antifibrotic effect by regulating the TGF-β/Smad signaling pathway in mouse model of unilateral ureteral obstruction. European Journal of Pharmacology, 910, N.PAG. https://doi.org/10.1016/j.ejphar.2021.174479
Chicago
Gairola, Shobhit, Chetan Ram, Abu Mohammad Syed, Pakpi Doye, Uttam Kulhari, Madhav Nilakanth Mugale, Upadhyayula Suryanarayana Murty, and Bidya Dhar Sahu. 2021. “Nootkatone Confers Antifibrotic Effect by Regulating the TGF-β/Smad Signaling Pathway in Mouse Model of Unilateral Ureteral Obstruction.” European Journal of Pharmacology 910 (November): N.PAG. doi:10.1016/j.ejphar.2021.174479.